Llwytho...
Relapsed disease and aspects of undetectable MRD and treatment discontinuation
Continuous treatment vs fixed duration of monotherapies and combinations of targeted agents are treatment options in relapsed chronic lymphocytic leukemia. The optimal choice of relapse treatment is dependent on the prior frontline therapy, duration of remission after frontline, genetic markers, and...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society of Hematology
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913464/ https://ncbi.nlm.nih.gov/pubmed/31808867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000070 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|